Medications for Growth Failure

4 results

  • Ngenla

    (somatrogon-ghla)
    Pfizer Laboratories Div Pfizer Inc
    Usage: NGENLA is indicated for treating pediatric patients aged 3 years and older with growth failure resulting from inadequate secretion of endogenous growth hormone.

  • Norditropin

    (somatropin)
    Novo Nordisk
    Usage: NORDITROPIN is indicated for pediatric patients with growth failure from inadequate growth hormone secretion, short stature due to Noonan or Turner syndrome, short stature born SGA, Idiopathic Short Stature, and Prader-Willi syndrome. For adults, it is used to replace endogenous growth hormone in those with deficiency.

  • Nutropin aq nuspin 5

    (somatropin)
    Genentech, Inc.
    Usage: Nutropin AQ is indicated for pediatric patients with growth failure from growth hormone deficiency, chronic kidney disease, idiopathic short stature, or Turner syndrome. In adults, it treats growth hormone deficiency due to pituitary or hypothalamic disorders, including those with a history of childhood-onset deficiency.

  • Skytrofa

    (Lonapegsomatropin-tcgd)
    Ascendis Pharma Endocrinology, Inc.
    Usage: SKYTROFA (lonapegsomatropin-tcgd) is indicated for treating pediatric patients aged 1 year and older, weighing at least 11.5 kg, with growth failure caused by inadequate secretion of endogenous growth hormone (GH).